Robert G. Kramer's most recent trade in Emergent Biosolutions Inc was a trade of 141,539 Employee Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 9, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 141,539 | 535,051 | - | - | Employee Stock Option (Right to buy) | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 141,539 | 506,059 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 70,769 | 364,520 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 38,462 | 293,751 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 38,462 | 258,182 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 19,231 | 255,289 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.38 per share. | 28 Feb 2023 | 3,226 | 103,298 (0%) | 0% | 12.4 | 39,938 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.71 per share. | 23 Feb 2023 | 1,591 | 106,524 (0%) | 0% | 13.7 | 21,813 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.30 per share. | 23 Feb 2023 | 1,428 | 108,115 (0%) | 0% | 14.3 | 20,420 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.25 per share. | 08 Feb 2023 | 4,944 | 109,543 (0%) | 0% | 13.3 | 65,508 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 278 | 114,487 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 135,330 | 135,330 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 55,582 | 248,684 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 33,833 | 193,102 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.64 per share. | 28 Feb 2022 | 1,715 | 246,969 (0%) | 0% | 39.6 | 67,983 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.47 per share. | 23 Feb 2022 | 2,034 | 159,269 (0%) | 0% | 42.5 | 86,384 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 23 Feb 2022 | 1,419 | 161,303 (0%) | 0% | 42.2 | 59,924 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.23 per share. | 22 Feb 2022 | 4,595 | 162,722 (0%) | 0% | 42.2 | 194,047 | Common Stock |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 4,264 | 167,317 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Robert G. Kramer | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.62 per share. | 08 May 2021 | 94 | 163,053 (0%) | 0% | 61.6 | 5,792 | Common Stock |